Paul J Clancy Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul J Clancy.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul J Clancy. Paul J Clancy is a Director in INCYTE CORP ($INCY) and a EVP, Chief Financial Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and a CFO in BIOGEN INC. ($IDPH) and an Executive VP and CFO in BIOGEN INC. ($IDPH) and a Director in EXACT SCIENCES CORP ($EXAS) and a Director in AGIOS PHARMACEUTICALS INC ($AGIO).
Address: 14 CAMBRIDGE CENTER CAMBRIDGE 02142 MA
Companies in which Paul J Clancy is an Insider
AGIOS PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul J Clancy: Director
Holdings: 3,278 shares
Current Value: $145,609
Latest Transaction: Jun 01 2020
$AGIO Market Capitalization: $1.88B
$AGIO Previous Close: $44.42
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ALEXION PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul J Clancy: EVP, Chief Financial Officer
Holdings: 90,447 shares
Current Value: $11,551,891
Latest Transaction: Jul 15 2019
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOGEN INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Paul J Clancy: Executive VP and CFO, CFO
Holdings: 10,813 shares
Latest Transaction: Apr 27 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
EXACT SCIENCES CORP
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Paul J Clancy: Director
Holdings: 2,929 shares
Current Value: $54,099
Latest Transaction: Mar 19 2021
$EXAS Market Capitalization: $2.00B
$EXAS Previous Close: $18.47
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INCYTE CORP
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Paul J Clancy: Director
Holdings: 5,094 shares
Current Value: $602,009
Latest Transaction: Apr 01 2021
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Paul J Clancy
Sentiment: All, AGIO, ALXN, IDPH, EXAS, INCY
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2021 | INCY | INCYTE CORP | Clancy Paul J | Director | Grant | A | 81.27 | 298 | 24,218 | 5,094 | 4.8 K to 5.1 K (+6.21 %) |
| Mar 19 2021 | EXAS | EXACT SCIENCES COR ... | Clancy Paul J | Director | Grant | A | 0.00 | 2,929 | 0 | 2,929 | 0 to 2.9 K |
| Oct 01 2020 | INCY | INCYTE CORP | Clancy Paul J | Director | Grant | A | 89.74 | 260 | 23,332 | 4,515 | 4.3 K to 4.5 K (+6.11 %) |
| Jul 01 2020 | INCY | INCYTE CORP | Clancy Paul J | Director | Grant | A | 103.97 | 229 | 23,809 | 4,255 | 4 K to 4.3 K (+5.69 %) |
| Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Clancy Paul J | Director | Option Exercise | M | 0.00 | 1,878 | 0 | 0 | |
| Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Clancy Paul J | Director | Option Exercise | A | 0.00 | 1,686 | 0 | 1,686 | |
| Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Clancy Paul J | Director | Option Exercise | A | 53.35 | 8,096 | 431,922 | 8,096 |